AbbVie earnings beat, Revenue misses in Q2

  • Investing.com
  • Stock Market News
AbbVie earnings beat, Revenue misses in Q2
Credit: © Reuters.

Investing.com - AbbVie (NYSE: ABBV ) reported on Friday second quarter earnings that beat analysts' forecasts and revenue that fell short of expectations.

AbbVie announced earnings per share of $3.37 on revenue of $14.58B. Analysts polled by Investing.com anticipated EPS of $3.34 on revenue of $14.67B.

AbbVie shares are up 10% from the beginning of the year and are trading at $150.10 , down-from-52-week-high.They are outperforming the S&P 500 which is down 14.56% year to date.

AbbVie shares gained 0.31% in pre-market trade the report.

AbbVie follows other major Healthcare sector earnings this month

AbbVie's report follows an earnings beat by UnitedHealth on Friday, July 15, 2022, who reported EPS of $5.57 on revenue of $80.33B, compared to forecasts EPS of $5.21 on revenue of $79.68B.

J&J had beat expectations on Tuesday, July 19, 2022 with second quarter EPS of $2.59 on revenue of $24.02B, compared to forecast for EPS of $2.54 on revenue of $23.77B.

Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar

Drop an image here or Supported formats: *.jpg, *.png, *.gif up to 5mb

Error: File type not supported

Drop an image here or

100

Related Articles